OBJECTIVE: To examine recent trends and differences in all-cause and cause-specific hospitalization rates by race, ethnicity, and gender among persons with HIV (PWH) in the United States and Canada. DESIGN: HIV clinical cohort consortium. METHODS: We followed PWH at least 18 years old in care 2005-2015 in six clinical cohorts. We used modified Clinical Classifications Software to categorize hospital discharge diagnoses. Incidence rate ratios (IRR) were estimated using Poisson regression with robust variances to compare racial and ethnic groups, stratified by gender, adjusted for cohort, calendar year, injection drug use history, and annually updated age, CD4+, and HIV viral load. RESULTS: Among 27 085 patients (122 566 person-years), 80% were cisgender men, 1% transgender, 43% White, 33% Black, 17% Hispanic of any race, and 1% Indigenous. Unadjusted all-cause hospitalization rates were higher for Black [IRR 1.46, 95% confidence interval (CI) 1.32-1.61] and Indigenous (1.99, 1.44-2.74) versus White cisgender men, and for Indigenous versus White cisgender women (2.55, 1.68-3.89). Unadjusted AIDS-related hospitalization rates were also higher for Black, Hispanic, and Indigenous versus White cisgender men (all P < 0.05). Transgender patients had 1.50 times (1.05-2.14) and cisgender women 1.37 times (1.26-1.48) the unadjusted hospitalization rate of cisgender men. In adjusted analyses, among both cisgender men and women, Black patients had higher rates of cardiovascular and renal/genitourinary hospitalizations compared to Whites (all P < 0.05). CONCLUSION: Black, Hispanic, Indigenous, women, and transgender PWH in the United States and Canada experienced substantially higher hospitalization rates than White patients and cisgender men, respectively. Disparities likely have several causes, including differences in virologic suppression and chronic conditions such as diabetes and renal disease.
OBJECTIVE: To examine recent trends and differences in all-cause and cause-specific hospitalization rates by race, ethnicity, and gender among persons with HIV (PWH) in the United States and Canada. DESIGN: HIV clinical cohort consortium. METHODS: We followed PWH at least 18 years old in care 2005-2015 in six clinical cohorts. We used modified Clinical Classifications Software to categorize hospital discharge diagnoses. Incidence rate ratios (IRR) were estimated using Poisson regression with robust variances to compare racial and ethnic groups, stratified by gender, adjusted for cohort, calendar year, injection drug use history, and annually updated age, CD4+, and HIV viral load. RESULTS: Among 27 085 patients (122 566 person-years), 80% were cisgender men, 1% transgender, 43% White, 33% Black, 17% Hispanic of any race, and 1% Indigenous. Unadjusted all-cause hospitalization rates were higher for Black [IRR 1.46, 95% confidence interval (CI) 1.32-1.61] and Indigenous (1.99, 1.44-2.74) versus White cisgender men, and for Indigenous versus White cisgender women (2.55, 1.68-3.89). Unadjusted AIDS-related hospitalization rates were also higher for Black, Hispanic, and Indigenous versus White cisgender men (all P < 0.05). Transgender patients had 1.50 times (1.05-2.14) and cisgender women 1.37 times (1.26-1.48) the unadjusted hospitalization rate of cisgender men. In adjusted analyses, among both cisgender men and women, Black patients had higher rates of cardiovascular and renal/genitourinary hospitalizations compared to Whites (all P < 0.05). CONCLUSION: Black, Hispanic, Indigenous, women, and transgender PWH in the United States and Canada experienced substantially higher hospitalization rates than White patients and cisgender men, respectively. Disparities likely have several causes, including differences in virologic suppression and chronic conditions such as diabetes and renal disease.
Authors: David A Wohl; Rita K Kuwahara; Kamran Javadi; Christine Kirby; David L Rosen; Sonia Napravnik; Claire Farel Journal: AIDS Patient Care STDS Date: 2017-10-17 Impact factor: 5.078
Authors: M D Stein; S Crystal; W E Cunningham; A Ananthanarayanan; R M Andersen; B J Turner; S Zierler; S Morton; M H Katz; S A Bozzette; M F Shapiro; M A Schuster Journal: Am J Public Health Date: 2000-07 Impact factor: 9.308
Authors: Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton Journal: N Engl J Med Date: 2015-07-20 Impact factor: 91.245
Authors: Keri N Althoff; Stephen J Gange; Marina B Klein; John T Brooks; Robert S Hogg; Ronald J Bosch; Michael A Horberg; Michael S Saag; Mari M Kitahata; Amy C Justice; Kelly A Gebo; Joseph J Eron; Sean B Rourke; M John Gill; Benigno Rodriguez; Timothy R Sterling; Liviana M Calzavara; Steven G Deeks; Jeffrey N Martin; Anita R Rachlis; Sonia Napravnik; Lisa P Jacobson; Gregory D Kirk; Ann C Collier; Constance A Benson; Michael J Silverberg; Margot Kushel; James J Goedert; Rosemary G McKaig; Stephen E Van Rompaey; Jinbing Zhang; Richard D Moore Journal: Clin Infect Dis Date: 2010-06-01 Impact factor: 9.079
Authors: Kate Jongbloed; Sherri Pooyak; Richa Sharma; Jennifer Mackie; Margo E Pearce; Nancy Laliberte; Lou Demerais; Richard T Lester; Martin T Schechter; Charlotte Loppie; Patricia M Spittal Journal: AIDS Behav Date: 2019-04
Authors: Cherise Wong; Stephen J Gange; Kate Buchacz; Richard D Moore; Amy C Justice; Michael A Horberg; M John Gill; John R Koethe; Peter F Rebeiro; Michael J Silverberg; Frank J Palella; Pragna Patel; Mari M Kitahata; Heidi M Crane; Alison G Abraham; Hasina Samji; Sonia Napravnik; Tareq Ahmed; Jennifer E Thorne; Ronald J Bosch; Angel M Mayor; Keri N Althoff Journal: Clin Infect Dis Date: 2017-02-15 Impact factor: 9.079
Authors: Kate Buchacz; Carl Armon; Frank J Palella; Rose K Baker; Ellen Tedaldi; Marcus D Durham; John T Brooks Journal: AIDS Res Treat Date: 2011-09-20